EUVIMEDEUVIMED entdecken
Crossref

Review of the reasons for and effectiveness of switching biologics for psoriasis treatment in Korea

Jun-Oh Shin, Bong Seok Shin, Kyung-Nam Bae, Kihyuk Shin, Hoon-Soo Kim, Hyun-Chang Ko, Moon-Bum Kim, Byungsoo Kim

Indian Journal of Dermatology, Venereology and Leprology · 2023

DOI: 10.25259/ijdvl_308_2022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, 2023. Verfasst von Jun-Oh Shin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea. Hauptthemen laut MEDLINE: Psoriasis, Biological Products. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Switching of biologics in patients has become common in clinical practice.

Objectives

This study investigated the reasons for and effectiveness of switching biologic agents during the treatment of psoriasis.

Methods

We retrospectively reviewed patients with psoriasis who were treated with biologics at Pusan National University Hospital and Chosun University Hospital from March 2012 to June 2020. We assessed their demographics and treatment characteristics (reasons for switching biologics and efficacy of the first- and second biologic agents).

Results

Of the 162 psoriatic patients treated with biologic agents for more than 52 weeks, 35 required a switch to another biologic agent. The reasons for switching biologic agents were inefficacy ( n = 30), adverse events ( n = 2) and others ( n = 3). The mean psoriasis area and severity index (PASI) score was 12.1 at the start of the second biologic and 3.4 at 14–16 weeks later. Patients were more likely to switch to another biologic agent when they exhibited a high initial psoriasis area and severity index score and concomitant psoriatic arthritis.

Limitations

As a retrospective study, there were some limitations such as lack of a placebo control group and the time point of 14–16 weeks being somewhat early to judge the effect of the biologics.

Conclusions

The most common reason for switching biologic agents in Korea was treatment inefficacy, especially secondary failure. Despite the inefficacy of previous biologic agents, switching to a different agent may be an efficacious approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisBiological ProductsHumansRetrospective StudiesBiological FactorsRepublic of KoreaTreatment OutcomeSeverity of Illness Index

Stichwörter der Autor:innen

Biologicspsoriasistreatment

Substanzen

Biological FactorsBiological Products

Autor:innen und Institutionen

  • Department of Dermatology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
  • Department of Dermatology, Chosun University Hospital, Gwangju, Republic of Korea.
  • Department of Dermatology, Pusan National University Hospital, Busan, Republic of Korea.

Zitieren

APA

Shin, J. O., Shin, B. S., Bae, K. N., Shin, K., Kim, H. S., Ko, H. C., Kim, M. B., & Kim, B. (2023). Review of the reasons for and effectiveness of switching biologics for psoriasis treatment in Korea. Indian Journal of Dermatology, Venereology and Leprology. https://doi.org/10.25259/ijdvl_308_2022

Vancouver

Shin JO, Shin BS, Bae KN, Shin K, Kim HS, Ko HC, et al. Review of the reasons for and effectiveness of switching biologics for psoriasis treatment in Korea. Indian Journal of Dermatology, Venereology and Leprology. 2023. doi:10.25259/ijdvl_308_2022

BibTeX
@article{Shin2023,
  author = {Shin, Jun-Oh and Shin, Bong Seok and Bae, Kyung-Nam and Shin, Kihyuk and Kim, Hoon-Soo and Ko, Hyun-Chang and Kim, Moon-Bum and Kim, Byungsoo},
  title = {Review of the reasons for and effectiveness of switching biologics for psoriasis treatment in Korea},
  journal = {Indian Journal of Dermatology, Venereology and Leprology},
  year = {2023},
  doi = {10.25259/ijdvl_308_2022}
}
Kostenlos starten →